1. Clinical & Scientific Overview
Cyanocobalamin (Vitamin B12) (TIP-MED-000370, Reference Code [10.1]-C100) is classified under
Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Water-Soluble Neurotropic & Haematinic Vitamin (Cobalamin; Coenzyme for Methionine Synthase & Methylmalonyl-CoA Mutase).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).
Co-indexed constituent under primary monograph [10.1] (Vitamin B12 (Methylcobalamin / Mecobalamin & Cyanocobalamin)). Representative Indian Market Examples (Edition 2.7 Ch 10 [10.1], p. 127): Nurokind / Nurokind-OD (Mankind—1500 mcg), Methycobal (Wockhardt—500 mcg, 1500 mcg), Meconerv (Micro Labs), Cobadex-CZS; Sublingual: Nurokind-Fast SL; Parenteral Injection: Methycobal 500 mcg / 1500 mcg ampoules, Neurobion Forte Inj — Strengths & Dosage Forms: Oral & Sublingual Tablets: 500 mcg, 1500 mcg (OD / Sustained-Release); Parenteral IM/IV Injection: 500 mcg/mL, 1000 mcg/mL, 1500 mcg/mL
Oral & Sublingual Tablets: 500 mcg, 1500 mcg (OD / Sustained-Release); Parenteral IM/IV Injection: 500 mcg/mL, 1000 mcg/mL, 1500 mcg/mL
3. Mechanism of Action & Pharmacodynamics
Water-Soluble Neurotropic & Haematinic Vitamin (Cobalamin; Coenzyme for Methionine Synthase & Methylmalonyl-CoA Mutase) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Water-Soluble Neurotropic & Haematinic Vitamin (Cobalamin; Coenzyme for Methionine Synthase & Methylmalonyl-CoA Mutase) for Vitamin B12 deficiency (dietary lacto-vegetarian deficiency, metformin-induced or chronic PPI-induced B12 malabsorption, pernicious anaemia); diabetic, alcoholic, and nutritional peripheral neuropathy (numbness, tingling, burning paresthesia); megaloblastic macrocytic anaemia; hyperhomocysteinaemia..
4. Therapeutic Indications & Evidence-Supported Uses
- Vitamin B12 deficiency (dietary lacto-vegetarian deficiency, metformin-induced or chronic PPI-induced B12 malabsorption, pernicious anaemia)
- diabetic, alcoholic, and nutritional peripheral neuropathy (numbness, tingling, burning paresthesia)
- megaloblastic macrocytic anaemia
- hyperhomocysteinaemia
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: Peripheral Neuropathy / Documented Oral Deficiency: Methylcobalamin 1500 mcg once daily (or 500 mcg three times daily) for 6 to 12 weeks, followed by maintenance 500–1500 mcg daily or alternate days (in chronic metformin/strict vegetarian patients). Severe Deficiency / Neurological Deficit (IM Injection): 1000–1500 mcg IM on alternate days for 5–7 doses, then weekly for 4 weeks, then monthly. Follow physician prescription.
Administration & Meal Timing: Oral tablets: With or without food (Sublingual tablets: place under tongue and allow to dissolve completely for 1–2 minutes without swallowing saliva immediately, bypassing gastric intrinsic factor requirement!). | Once daily in the morning after breakfast (morning administration avoids mild alerting/insomnia occasionally reported at night).
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Follows class pharmacokinetic profile detailed in parent monograph [10.1].
Renal: Prefer Methylcobalamin (Mecobalamin) over Cyanocobalamin in Chronic Kidney Disease! (Cyanocobalamin releases a cyanide moiety that is normally cleared by the kidneys and can accumulate in ESRD/dialysis patients; Methylcobalamin is already the active methylated cofactor and requires no cyanide detoxification!). Hepatic: Safe.
Renal: Prefer Methylcobalamin (Mecobalamin) over Cyanocobalamin in Chronic Kidney Disease! (Cyanocobalamin releases a cyanide moiety that is normally cleared by the kidneys and can accumulate in ESRD/dialysis patients; Methylcobalamin is already the active methylated cofactor and requires no cyanide detoxification!). Hepatic: Safe.
Renal: Prefer Methylcobalamin (Mecobalamin) over Cyanocobalamin in Chronic Kidney Disease! (Cyanocobalamin releases a cyanide moiety that is normally cleared by the kidneys and can accumulate in ESRD/dialysis patients; Methylcobalamin is already the active methylated cofactor and requires no cyanide detoxification!). Hepatic: Safe.
7. Contraindications, Precautions & High-Risk Warnings
- Contraindicated in Leber's hereditary optic neuropathy (cyanocobalamin can precipitate rapid optic atrophy!) and cobalt allergy. Diagnostic Precaution: In megaloblastic anaemia, always check both Vitamin B12 and Folic Acid—giving high-dose Folic Acid alone without Vitamin B12 corrects the blood count while allowing irreversible spinal cord damage (subacute combined degeneration) to progress!
Key Clinical Precautions: Renal: Prefer Methylcobalamin (Mecobalamin) over Cyanocobalamin in Chronic Kidney Disease! (Cyanocobalamin releases a cyanide moiety that is normally cleared by the kidneys and can accumulate in ESRD/dialysis patients; Methylcobalamin is already the active methylated cofactor and requires no cyanide detoxification!). Hepatic: Safe.
8. Adverse Effects Profile
- Exceptionally well tolerated (excess water-soluble B12 is excreted in urine); rare mild nausea, headache, or acneiform/rosacea-like skin eruptions with high parenteral doses.
- Hypokalaemia during initial treatment of severe megaloblastic anaemia (rapid erythrocyte regeneration consumes extracellular potassium—monitor K+ in the first 48–72 hours!), rare anaphylaxis with parenteral injections (due to excipients/cobalt).
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Metformin (decreases ileal calcium-dependent B12-Intrinsic Factor uptake), Proton Pump Inhibitors (pantoprazole, omeprazole—suppress gastric acid needed to cleave B12 from food proteins), Colchicine, Neomycin, Para-aminosalicylic acid, and Heavy Alcohol impair oral Vitamin B12 absorption! Chloramphenicol blunts haematopoietic response
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent monograph [10.1].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: Explain why Methylcobalamin 1500 mcg (Nurokind-OD / Methycobal) is so widely prescribed in India: ~1% of an oral 1500 mcg dose (~15 mcg) absorbs by passive diffusion across the gut wall even when Intrinsic Factor or stomach acid is impaired by age, Metformin, or Pantoprazole! Protect Methylcobalamin strips and ampoules from light (photolabile—rapidly degrades if exposed to sunlight).
- Meal & Clock Timing Instruction: Oral tablets: With or without food (Sublingual tablets: place under tongue and allow to dissolve completely for 1–2 minutes without swallowing saliva immediately, bypassing gastric intrinsic factor requirement!). (Once daily in the morning after breakfast (morning administration avoids mild alerting/insomnia occasionally reported at night).)
- Missed Dose Protocol: Take as soon as remembered on the same day; do not double.
- Geriatric Dispensing Pearl: Up to 40–50% of elderly Indian patients (especially vegetarians taking Metformin and PPIs) have subclinical or overt Vitamin B12 deficiency presenting as memory loss, unsteady gait, depression, or burning feet—screen and supplement proactively.
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral & Sublingual Tablets: 500 mcg, 1500 mcg (OD / Sustained-Release); Parenteral IM/IV Injection: 500 mcg/mL, 1000 mcg/mL, 1500 mcg/mL
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [10.3]-C106 B9 — Water-Soluble Coenzyme Vitamin Complex (Carbohydrate, Amino Acid
- [10.3]-C107 B12) — Water-Soluble Coenzyme Vitamin Complex (Carbohydrate, Amino Acid
- [10.4]-C108 Multiminerals — Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D
- [10.5]-C109 Vitamin D3 (Cholecalciferol) — Inorganic Calcium Salt (40% Elemental Calcium—Highest Elemental Y